Ferring Pharmaceuticals Inc. v. Par Pharmaceutical, Inc.
Ferring Pharmaceuticals Inc. v. Par Pharmaceutical, Inc.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ FERRING PHARMACEUTICALS INC., FERRING INTERNATIONAL CENTER SA, Plaintiffs-Appellees v. PAR PHARMACEUTICAL, INC., Defendant-Appellant ______________________ 2017-2399 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:15-cv-00173-RGA, Judge Richard G. Andrews. ______________________ JUDGMENT ______________________ MARY W. BOURKE, Womble Bond Dickinson (US) LLP, Wilmington, DE, argued for plaintiffs-appellees. Also represented by DANIEL M. ATTAWAY, DANA KATHRYN SEVERANCE; JOHN W. COX, Atlanta, GA. RICHARD J. BERMAN, Arent Fox, LLP, Washington, DC, argued for defendant-appellant. Also represented by TANIEL ERMANO ANDERSON, JANINE A. CARLAN. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
PER CURIAM (REYNA, SCHALL, and STOLL, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
June 8, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Case-law data current through December 31, 2025. Source: CourtListener bulk data.